UM729, 250 µg - StemCell Technologies

Product Overview:
UM729 is a pyrimido-[4,5-b]-indole derivative that enhances the self-renewal of human hematopoietic stem cells (HSCs) in vitro. It does not inhibit the aryl hydrocarbon receptor (AHR) pathway but collaborates with AHR antagonists to prevent differentiation of acute myeloid leukemia (AML) cells in culture. This makes UM729 a valuable tool in stem cell and cancer research.

Specifications:

• Quantity: 250 µg of active compound
• Molecular Formula: C₂₀H₂₅N₅O₂ · X HCl [X H₂O]
• Purity: ?95%

Manufacturer Information:
StemCell Technologies Canada Inc. is a biotechnology company based in Vancouver, British Columbia, Canada. Founded in 1993 by Dr. Allen Eaves, the company specializes in developing and manufacturing cell culture media and cell separation technologies for use in stem cell, immunology, and cancer research. With over 2,500 employees, StemCell Technologies delivers more than 2,500 products to scientists worldwide. For more information, visit their website at www.stemcell.com.